This meeting is suitable for consultant surgeons, oncologists and gastroenterologists involved in the treatment and support of patients who have undergone therapy for pelvic malignancies.
We will cover gastrointestinal, urinary and sexual side-effects, review the latest concepts of best practice and discuss developing future pathways to improve patient experience.
Course Cost: £95.00
Dr Jervoise Andreyev, Brendan Moran and Francesco Di Fabio
Reduced course fees are available for individual roles.
Convenors: Mr Francesco di Fabio and Mrs Kerry Feltwell
08.45 Welcome & introduction – Mr Jervoise Andreyev
08.50 The patient’s perspective – Mr David Jillings
Chair: Brendan Moran The scale and range of acute and chronic GI toxicity.
09.20 An overview of bowel toxicity issues and treatment – Dr Jervoise Andreyev
09.45 The oncologists view on the size and nature of the problem – Prof David Sebag Montefiore
10.10 Panel Discussion – Panel: as above + SL
Chair: David Sebag-Montefiore Recognising the issues
11.15 From “one size fits all” to personalized treatment planning – Mr Francesco Di Fabio
11.30 Multi-disciplinary collaboration on bladder and sexual dysfunction after surgery – Mr Christian Philips
11.50 Anterior resection syndrome – Prof Soren Lauberg
Chair: Soren Laurber
12.20 The psychological and psychiatric morbidity of cancer treatment and effective management – Dr. Andrew Hodgkiss
12.40 The economics of GI toxicity – Dr. Mirella Longo
13.45 Case study – Panel: JV, F Di F, SL, CV, PK, TD, AH
14.15 Managing incontinence and diarrhea – Dr. Mirella Longo
14.35 The role of sacral nerve stimulation in managing ARS – Mr Tom Dudding
Chair: Jervoise Andreyev Measuring Low Anterior Resection Syndrome
15.50 Outcomes – Prof Soren Laurberg
16.15 Questions and discussion
16.30 Summary and close